Literature DB >> 7977638

Detection of interleukin-1 receptors in human epidermis. Induction of the type II receptor after organ culture and in psoriasis.

R W Groves1, L Sherman, H Mizutani, S K Dower, T S Kupper.   

Abstract

Normal human epidermis is a rich source of biologically active interleukin-1 alpha (IL-1 alpha). Keratinocytes both synthesize this cytokine and respond to it via cell surface receptors (IL-1R), suggesting that the IL-1 system may play an important role in normal epidermal physiology and inflammation. In this study, we have examined the expression of IL-1R in normal and psoriatic epidermis, as judged at a functional level by the capacity to bind 125I-labeled IL-1 alpha (the principal IL-1 species present in epidermis) and by immunostaining with antibodies specific for each species of IL-1R. IL-1R was not readily detectable by either technique in normal, freshly isolated human epidermis. However, in lesional psoriasis or normal epidermis after 24 hours of organ culture, expression of IL-1R was dramatically induced, especially in basal keratinocytes. Immunostaining and antibody blocking studies demonstrated the induced IL-1R to be the type II species, a nonsignal transducing molecule previously demonstrated only on leukocytes. The Ka of this receptor was comparable to that previously demonstrated in vitro. mRNA for both species of IL-1R could be demonstrated by reverse transcriptase-polymerase chain reaction in fresh and cultured epidermis. These in vivo findings were confirmed in culture, where normal human keratinocytes expressed few IL-1R at rest but large numbers of type II IL-1R after activation by phorbol ester or interferon-gamma. We conclude that under resting conditions, epidermal expression of IL-1R is low. However, the potential for keratinocytes in vivo to express large numbers of the nonsignal transducing type II IL-1R is evident from both organ cultured and psoriatic epidermis. The in vitro induction of keratinocyte IL-1R by interferon-gamma suggests that this cytokine may be involved in the induction of type II IL-1R in inflammatory skin disease. The presence of bioactive IL-1 in epidermis, coupled with the inducible expression of the decoy type II IL-1R, indicates the existence of a highly regulated system of autocrine stimulation of keratinocytes by IL-1.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7977638      PMCID: PMC1887420     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  18 in total

Review 1.  Immune and inflammatory processes in cutaneous tissues. Mechanisms and speculations.

Authors:  T S Kupper
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

2.  Presence of epidermal-derived thymocyte activating factor/interleukin 1 in normal human stratum corneum.

Authors:  L C Gahring; A Buckley; R A Daynes
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

3.  cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily.

Authors:  J E Sims; C J March; D Cosman; M B Widmer; H R MacDonald; C J McMahan; C E Grubin; J M Wignall; J L Jackson; S M Call
Journal:  Science       Date:  1988-07-29       Impact factor: 47.728

4.  Interleukin 1 is present in normal human epidermis.

Authors:  C Hauser; J H Saurat; A Schmitt; F Jaunin; J M Dayer
Journal:  J Immunol       Date:  1986-05-01       Impact factor: 5.422

5.  Altered [125I]epidermal growth factor binding and receptor distribution in psoriasis.

Authors:  L B Nanney; C M Stoscheck; M Magid; L E King
Journal:  J Invest Dermatol       Date:  1986-03       Impact factor: 8.551

6.  Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4.

Authors:  F Colotta; F Re; M Muzio; R Bertini; N Polentarutti; M Sironi; J G Giri; S K Dower; J E Sims; A Mantovani
Journal:  Science       Date:  1993-07-23       Impact factor: 47.728

7.  Interleukin-1 receptor antagonist production by human keratinocytes.

Authors:  C F Bigler; D A Norris; W L Weston; W P Arend
Journal:  J Invest Dermatol       Date:  1992-01       Impact factor: 8.551

8.  Effect of in vivo interleukin-1 on adhesion molecule expression in normal human skin.

Authors:  R W Groves; E Ross; J N Barker; J S Ross; R D Camp; D M MacDonald
Journal:  J Invest Dermatol       Date:  1992-03       Impact factor: 8.551

Review 9.  Interleukin-1 and interleukin-1 antagonism.

Authors:  C A Dinarello
Journal:  Blood       Date:  1991-04-15       Impact factor: 22.113

10.  Independent binding of interleukin-1 alpha and interleukin-1 beta to type I and type II interleukin-1 receptors.

Authors:  J Slack; C J McMahan; S Waugh; K Schooley; M K Spriggs; J E Sims; S K Dower
Journal:  J Biol Chem       Date:  1993-02-05       Impact factor: 5.157

View more
  19 in total

1.  Role of FGFR2-signaling in the pathogenesis of acne.

Authors:  Bodo C Melnik
Journal:  Dermatoendocrinol       Date:  2009-05

2.  Keratinocyte expression of the type 2 interleukin 1 receptor mediates local and specific inhibition of interleukin 1-mediated inflammation.

Authors:  T Rauschmayr; R W Groves; T S Kupper
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-27       Impact factor: 11.205

3.  Inflammatory and hyperproliferative skin disease in mice that express elevated levels of the IL-1 receptor (type I) on epidermal keratinocytes. Evidence that IL-1-inducible secondary cytokines produced by keratinocytes in vivo can cause skin disease.

Authors:  R W Groves; T Rauschmayr; K Nakamura; S Sarkar; I R Williams; T S Kupper
Journal:  J Clin Invest       Date:  1996-07-15       Impact factor: 14.808

4.  Interleukin-1β-induced Reduction of CD44 Ser-325 Phosphorylation in Human Epidermal Keratinocytes Promotes CD44 Homomeric Complexes, Binding to Ezrin, and Extended, Monocyte-adhesive Hyaluronan Coats.

Authors:  Tiina Jokela; Sanna Oikari; Piia Takabe; Kirsi Rilla; Riikka Kärnä; Markku Tammi; Raija Tammi
Journal:  J Biol Chem       Date:  2015-03-25       Impact factor: 5.157

5.  Enhanced epithelial proliferation due to elevated levels of interleukin-1 receptors in middle ear cholesteatomas.

Authors:  J Bujia; C Kim; P Ostos-Aumente; J Lopez-Villarejo; E Kastenbauer
Journal:  Eur Arch Otorhinolaryngol       Date:  1997       Impact factor: 2.503

6.  Retinoid-responsive transcriptional changes in epidermal keratinocytes.

Authors:  Ding-Dar Lee; Olivera Stojadinovic; Agata Krzyzanowska; Constantinos Vouthounis; Miroslav Blumenberg; Marjana Tomic-Canic
Journal:  J Cell Physiol       Date:  2009-08       Impact factor: 6.384

7.  Increased expression of interleukin-4 receptors on psoriatic epidermal cells.

Authors:  E Prens; J Hegmans; R C Lien; R Debets; R Troost; T van Joost; R Benner
Journal:  Am J Pathol       Date:  1996-05       Impact factor: 4.307

8.  Inflammatory skin disease in transgenic mice that express high levels of interleukin 1 alpha in basal epidermis.

Authors:  R W Groves; H Mizutani; J D Kieffer; T S Kupper
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-05       Impact factor: 11.205

Review 9.  Regulation of IL-1 signaling by the decoy receptor IL-1R2.

Authors:  Thomas Schlüter; Carsten Schelmbauer; Khalad Karram; Ilgiz A Mufazalov
Journal:  J Mol Med (Berl)       Date:  2018-08-15       Impact factor: 4.599

10.  Transfected type II interleukin-1 receptor impairs responsiveness of human keratinocytes to interleukin-1.

Authors:  P Bossù; U Visconti; P Ruggiero; G Macchia; M Muda; R Bertini; C Bizzarri; A Colagrande; V Sabbatini; G Maurizi
Journal:  Am J Pathol       Date:  1995-12       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.